Adient (ADNT) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Adient (ADNT) reported revenue of $3.74 billion, up 0.7% over the same period last year. EPS came in at $0.45, compared to $0.32 in the year-ago quarter.The reported revenue represents a surprise of +5.08% over the Zacks Consensus Estimate of $3.56 billion. With the consensus EPS estimate being $0.47, the EPS surprise was -4.26%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Adient performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Light Vehicle Production - Global: 22.6 million versus the two-analyst average estimate of 21.97 million.Light Vehicle Production - North America: 4 million versus 3.81 million estimated by two analysts on average.Light Vehicle Production - Asia, excluding China, and Other: 5.9 million versus the two-analyst average estimate of 5.6 million.Light Vehicle Production - EMEA: 4.4 million versus 4.35 million estimated by two analysts on average.Light Vehicle Production - China: 7.6 million versus the two-analyst average estimate of 7.47 million.Light Vehicle Production - South America: 0.7 million versus the two-analyst average estimate of 0.75 million.Net Sales- Americas: $1.76 billion compared to the $1.59 billion average estimate based on two analysts. The reported number represents a change of +1.3% year over year.Net Sales- Eliminations: $-8 million compared to the $-25.92 million average estimate based on two analysts. The reported number represents a change of -61.9% year over year.Net Sales- Asia: $721 million compared to the $739.34 million average estimate based on two analysts. The reported number represents a change of +1.3% year over year.Net Sales- EMEA: $1.27 billion versus $1.22 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.6% change.View all Key Company Metrics for Adient here>>>Shares of Adient have returned -0.2% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Adient (ADNT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks